203 results
424B5
ENVB
Enveric Biosciences Inc
3 May 24
Prospectus supplement for primary offering
5:05pm
pipeline assets to Akos Biosciences, Inc. (formerly known as Acanna Therapeutics, Inc.), a majority-owned subsidiary of the Company (hereafter referred … ”). As a result of the 2015 Merger, Ameri and Partners became Ameri’s wholly owned subsidiary with Ameri and Partners’ former stockholders acquiring a majority
424B5
ENVB
Enveric Biosciences Inc
11 Mar 24
Prospectus supplement for primary offering
12:35pm
Biosciences, Inc. (formerly known as Acanna Therapeutics, Inc.), a majority-owned subsidiary of the Company (hereafter referred to as “Akos”), which … subsidiary with Ameri and Partners’ former stockholders acquiring a majority of the outstanding shares of Ameri common stock. The 2015 Merger
8-K
EX-4.1
ln1fkrzns1deuw2zjl
29 Dec 23
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
eb9xpuuq
29 Dec 23
Entry into a Material Definitive Agreement
4:43pm
424B4
r978sdkm ba5s
6 Dec 23
Prospectus supplement with pricing info
4:00pm
8-K
EX-10.1
5bdn198w3ni
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
EX-10.1
69glw17782png8
2 Nov 23
Departure of Directors or Certain Officers
5:29pm
424B5
p3yl12
1 Sep 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
44s8rgz3s2hmoi
18 May 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
8:00am